Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
片頭痛の新治療:CGRP関連薬の有効性・副作用・日常生活での使いこなし
|
Dec 12, 2025 |
|
妊娠・産後期の母子ケア:産後うつ・育児ストレス・母体代謝変化のエビデンスと対応策
|
Dec 05, 2025 |
|
患者の“声なき声”を拾う:非言語的サインや行動変化からニーズを察知する方法
|
Nov 28, 2025 |
|
婦人科領域の予防医療
|
Nov 20, 2025 |
|
マイクロバイオームと内科疾患:腸内細菌叢が慢性疾患に与える影響と治療介入
|
Nov 17, 2025 |
|
リハビリテーションの科学 神経可塑性に基づく機能回復の最新知見
|
Nov 07, 2025 |
|
睡眠と心身の健康:睡眠の質・時間と慢性疾患リスクの最新エビデンス
|
Oct 31, 2025 |
|
AI診断の今と未来:画像診断AIの精度・限界・実装時の留意点
|
Oct 27, 2025 |
|
医療現場のチーム力と多職種連携の実践事例
|
Oct 18, 2025 |
|
治療の継続率を高める支援策:海外研究から見えた継続支援の実例と効果
|
Oct 11, 2025 |
|
医療者と患者の信頼関係を構築するコミュニケーション
|
Oct 03, 2025 |
|
AYA世代(思春期・若年成人)がん患者の支援の現状
|
Sep 19, 2025 |
|
腫瘍微小環境における免疫抑制機構の解明
|
Sep 12, 2025 |
|
前立腺がん治療におけるPSMA標的療法の台頭
|
Sep 05, 2025 |
|
非小細胞肺がん免疫療法の進展
|
Aug 29, 2025 |
|
がん緩和ケアの最前線と患者支援の具体例
|
Aug 22, 2025 |
|
番組リニューアルのお知らせ
|
Aug 20, 2025 |
|
Language Change Announcement – Japanese Only Going(番組リニューアルのお知らせとお詫び)
|
Aug 20, 2025 |
|
【日】Neoadjuvant Chemotherapy, Case Volume, and Mortality in Advanced Ovarian Cancer.
|
Aug 15, 2025 |
|
【英】Neoadjuvant Chemotherapy, Case Volume, and Mortality in Advanced Ovarian Cancer
|
Aug 15, 2025 |
|
【日】Structured Exercise after Adjuvant Chemotherapy for Colon Cancer.
|
Aug 04, 2025 |
|
【英】Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
|
Aug 04, 2025 |
|
【日】Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer.
|
Jul 31, 2025 |
|
【英】Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
|
Jul 31, 2025 |
|
【日】Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer
|
Jul 25, 2025 |
|
【英】Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer
|
Jul 25, 2025 |
|
【日】Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.
|
Jul 11, 2025 |
|
【英】Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
|
Jul 11, 2025 |
|
【日】Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer Survivors.
|
Jul 04, 2025 |
|
【英】Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer Survivors
|
Jul 04, 2025 |
|
【日】Assessment of a Polygenic Risk Score in Screening for Prostate Cancer
|
Jun 27, 2025 |
|
【英】Assessment of a Polygenic Risk Score in Screening for Prostate Cancer
|
Jun 27, 2025 |
|
【日】Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer.
|
Jun 20, 2025 |
|
【英】Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
|
Jun 20, 2025 |
|
【日】ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial.
|
Jun 13, 2025 |
|
【英】ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial.
|
Jun 13, 2025 |
|
【日】Tomosynthesis vs Digital Mammography Screening in Women with a Family History of Breast Cancer.
|
Jun 06, 2025 |
|
【英】Tomosynthesis vs Digital Mammography Screening in Women with a Family History of Breast Cancer.
|
Jun 06, 2025 |
|
【日】Ponsegromab for the Treatment of Cancer Cachexia
|
May 30, 2025 |
|
【英】Ponsegromab for the Treatment of Cancer Cachexia
|
May 30, 2025 |
|
【日】Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer
|
May 23, 2025 |
|
【英】Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer
|
May 23, 2025 |
|
【日】Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
|
May 16, 2025 |
|
【英】Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
|
May 16, 2025 |
|
【日】Preferences for Communication About Prognosis Among Children With Cancer, Parents, and Oncologists
|
May 12, 2025 |
|
【英】Preferences for Communication About Prognosis Among Children With Cancer, Parents, and Oncologists
|
May 12, 2025 |
|
【日】Preoperative Clinical and Tumor Factors Associated With Adjuvant Therapy for Oral Cavity Cancer
|
Apr 30, 2025 |
|
【英】Preoperative Clinical and Tumor Factors Associated With Adjuvant Therapy for Oral Cavity Cancer
|
Apr 30, 2025 |
|
【日】Imlunestrant with or without Abemaciclib in Advanced Breast Cancer.
|
Apr 21, 2025 |
|
【英】Imlunestrant with or without Abemaciclib in Advanced Breast Cancer.
|
Apr 21, 2025 |
|
【日】Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer.
|
Apr 11, 2025 |
|
【英】Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer.
|
Apr 11, 2025 |
|
【日】Algorithm-Based Palliative Care in Patients With Cancer: A Cluster Randomized Clinical Trial.
|
Apr 04, 2025 |
|
【英】Algorithm-Based Palliative Care in Patients With Cancer: A Cluster Randomized Clinical Trial
|
Apr 04, 2025 |
|
【日】Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study.
|
Mar 31, 2025 |
|
【英】Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study.
|
Mar 31, 2025 |
|
【日】Aspirin Use and Incidence of Colorectal Cancer According to Lifestyle Risk.
|
Mar 24, 2025 |
|
【英】Aspirin Use and Incidence of Colorectal Cancer According to Lifestyle Risk.
|
Mar 24, 2025 |
|
【日】Incidence of Newly Diagnosed Cancer After Cerebral Venous Thrombosis.
|
Mar 13, 2025 |
|
【英】Incidence of Newly Diagnosed Cancer After Cerebral Venous Thrombosis
|
Mar 13, 2025 |
|
【日】Cancer Survivorship Care in the United States at Facilities Accredited by the Commission on Cancer
|
Mar 07, 2025 |
|
【英】Cancer Survivorship Care in the United States at Facilities Accredited by the Commission on Cancer
|
Mar 07, 2025 |
|
【日】Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
|
Feb 27, 2025 |
|
【英】Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
|
Feb 27, 2025 |
|
【日】Colorectal Cancer and Central Obesity.
|
Feb 19, 2025 |
|
【英】Colorectal Cancer and Central Obesity.
|
Feb 19, 2025 |
|
【日】Results after Four Years of Screening for Prostate Cancer with PSA and MRI.
|
Feb 17, 2025 |
|
【英】Results after Four Years of Screening for Prostate Cancer with PSA and MRI.
|
Feb 17, 2025 |
|
【日】Primary Care Use and 90-Day Mortality Among Older Adults Undergoing Cancer Surgery.
|
Feb 07, 2025 |
|
【英】Primary Care Use and 90-Day Mortality Among Older Adults Undergoing Cancer Surgery.
|
Feb 07, 2025 |
|
【日】Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density.
|
Jan 30, 2025 |
|
【英】Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density
|
Jan 30, 2025 |
|
【日】Cataracts Associated With Fibroblast Growth Factor Receptor Inhibitors for Cholangiocarcinoma.
|
Jan 27, 2025 |
|
【英】Cataracts Associated With Fibroblast Growth Factor Receptor Inhibitors for Cholangiocarcinoma.
|
Jan 27, 2025 |
|
【日】Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data.
|
Jan 20, 2025 |
|
【英】Colorectal cancer incidence trends in younger versus older adults an analysis of population-based cancer registry data.
|
Jan 20, 2025 |
|
【日】Survival Outcomes of an Early Intervention Smoking Cessation Treatment After a Cancer Diagnosis
|
Jan 10, 2025 |
|
【英】Survival Outcomes of an Early Intervention Smoking Cessation Treatment After a Cancer Diagnosis
|
Jan 10, 2025 |
|
【日】Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer
|
Dec 23, 2024 |
|
【英】Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer
|
Dec 23, 2024 |
|
【日】Patient, Caregiver, and Clinician Perspectives on the Time Burdens of Cancer Care
|
Dec 20, 2024 |
|
【英】Patient, Caregiver, and Clinician Perspectives on the Time Burdens of Cancer Care
|
Dec 20, 2024 |
|
【日】Preoperative Chemoradiotherapy for Resectable Gastric Cancer
|
Dec 16, 2024 |
|
【英】Preoperative Chemoradiotherapy for Resectable Gastric Cancer.
|
Dec 16, 2024 |
|
【英】Psoriasis Risk With Immune Checkpoint Inhibitors
|
Dec 10, 2024 |
|
【日】Psoriasis Risk With Immune Checkpoint Inhibitors
|
Dec 10, 2024 |
|
【日】Cardiovascular Events After Chimeric Antigen Receptor T-Cell Therapy for Advanced Hematologic Malignant Neoplasms: A Meta-Analysis
|
Dec 03, 2024 |
|
【英】Cardiovascular Events After Chimeric Antigen Receptor T-Cell Therapy for Advanced Hematologic Malignant Neoplasms: A Meta-Analysis
|
Dec 03, 2024 |
|
【日】Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-Risk Resected Melanoma
|
Nov 25, 2024 |
|
【英】Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-Risk Resected Melanoma
|
Nov 25, 2024 |
|
【日】Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer N Engl J Med 2024;391:1206-1216.
|
Nov 18, 2024 |
|
【英】Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer N Engl J Med 2024;391:1206-1216.
|
Nov 18, 2024 |
|
【日】Stepped Palliative Care for Patients With Advanced Lung Cancer A Randomized Clinical Trial JAMA . 2024 Aug 13;332(6):471-481.
|
Nov 11, 2024 |
|
【英】Stepped Palliative Care for Patients With Advanced Lung Cancer A Randomized Clinical Trial JAMA . 2024 Aug 13;332(6):471-481.
|
Nov 11, 2024 |
|
【日】Parastomal Hernia Prevention Using Funnel-Shaped Intra-Abdominal Mesh Compared to No Mesh: The Chimney Randomized Clinical Trial JAMA Surg. 2024 Aug 28:e243260.
|
Nov 01, 2024 |
|
【英】Parastomal Hernia Prevention Using Funnel-Shaped Intra-Abdominal Mesh Compared to No Mesh: The Chimney Randomized Clinical Trial JAMA Surg. 2024 Aug 28:e243260.
|
Nov 01, 2024 |
|
【日】Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat Med . 1996 May;2(5):561-6
|
Oct 23, 2024 |
|
【英】Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat Med . 1996 May;2(5):561-6
|
Oct 23, 2024 |